Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Immune Cells Activity”

570 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 570 results

Not applicableActive Not RecruitingNCT05236764
What this trial is testing

Haploidentical Hematopoietic Cell Transplantation Using TCR Alpha/Beta and CD19 Depletion

Who this might be right for
Acute Lymphoblastic Leukemia in RemissionAcute Myeloid Leukemia in RemissionMyelodysplastic Syndromes+8 more
Baylor College of Medicine 3
Testing effectiveness (Phase 2)Ended earlyNCT01248455
What this trial is testing

A Phase II Trial of Anti-KIR in Smoldering Multiple Myeloma

Who this might be right for
Multiple MyelomaMyelomaSmoldering Multiple Myeloma
National Cancer Institute (NCI) 9
Not applicableStudy completedNCT04629274
What this trial is testing

In Vitro Study of the Biological and Immunological Activity of Imotopes® Candidates on Blood Cells of Patients With Stabilized NMO

Who this might be right for
Neuromyelitis Optica
Imcyse SA 15
Not applicableUnknownNCT04208074
What this trial is testing

Exercise Study for Breast Cancer Survivors

Who this might be right for
Breast Cancer
San Diego Biomedical Research Institute 30
Early research (Phase 1)Ended earlyNCT04978779
What this trial is testing

Evaluate VIP152 in Subjects With Relapsed/Refractory Chronic Lymphocytic Leukemia or Richter Syndrome

Who this might be right for
Relapsed Non Hodgkin LymphomaChronic Lymphocytic LeukemiaRefractory Chronic Lymphocytic Leukemia+4 more
Vincerx Pharma, Inc. 6
Testing effectiveness (Phase 2)Study completedNCT03262389
What this trial is testing

Comparison of F-18 FDG and C-11 Acetate PET in Multiple Myeloma

Who this might be right for
Multiple Myeloma
Michael C Roarke, MD 10
Testing effectiveness (Phase 2)Active Not RecruitingNCT06056791
What this trial is testing

Study of INKmune in Patients With mCRPC (CaRe Prostate)

Who this might be right for
CancerMetastatic Castration-resistant Prostate CancermCRPC
Inmune Bio, Inc. 30
Early research (Phase 1)Looking for participantsNCT04795882
What this trial is testing

A New Study Evaluating the Activity of Modular CAR T for mYeloma

Who this might be right for
Multiple Myeloma
University College, London 27
Not applicableActive Not RecruitingNCT04000880
What this trial is testing

Adapting Multiple Behavior Interventions That Effectively Improve Cancer Survivor Health Cancer Survivor Health

Who this might be right for
Breast CancerColorectal CancerEndometrial Cancer+6 more
University of Alabama at Birmingham 603
Testing effectiveness (Phase 2)Study completedNCT03543813
What this trial is testing

PROCLAIM-CX-2029: A Trial to Find Safe and Active Doses of an Investigational Drug CX-2029 for Patients With Solid Tumors or DLBCL

Who this might be right for
Solid Tumor, AdultHead and Neck CancerNon Small Cell Lung Cancer+2 more
CytomX Therapeutics 133
Early research (Phase 1)WithdrawnNCT00538096
What this trial is testing

A Phase I Study to Evaluate Safety, Tolerability in Adults With Lymphoma

Who this might be right for
Lymphoma, B-CellLymphoma, Non-Hodgkin
MedImmune LLC 18
Not applicableLooking for participantsNCT06737224
What this trial is testing

The Impact of a 48-hour Fast with or Without Exercise on Immune Cell Metabolism and Glycemic Control in Healthy Active Adults

Who this might be right for
FastingImmune FunctionGlucose Tolerance
University of British Columbia 15
Early research (Phase 1)Study completedNCT02316197
What this trial is testing

Clinical Phase I Study Investigating MSC2490484A, an Inhibitor of a DNA-dependent Protein Kinase, in Advanced Solid Tumors or Chronic Lymphocytic Leukemia

Who this might be right for
Advanced Solid TumorsChronic Lymphocytic Leukemia
Merck KGaA, Darmstadt, Germany 31
Very early researchWithdrawnNCT06548620
What this trial is testing

RD06-04 in Patients With Active Autoimmune Diseases

Who this might be right for
SLESclerosisANCA Associated Vasculitis+5 more
Nanjing Bioheng Biotech Co., Ltd.
Not applicableActive Not RecruitingNCT02194387
What this trial is testing

Energy Balance Interventions in Increasing Physical Activity in Breast Cancer Gene Positive Patients, Lynch Syndrome-Positive Patients, CLL Survivors or High-Risk Family Members

Who this might be right for
Body Mass Index 25 or GreaterBRCA1 Gene MutationBRCA2 Gene Mutation+8 more
M.D. Anderson Cancer Center 337
Early research (Phase 1)Ended earlyNCT02669264
What this trial is testing

Study of ADCT-402 in Patients With Relapsed or Refractory B-cell Lineage Acute Lymphoblastic Leukemia (B-ALL)

Who this might be right for
Acute Lymphoblastic Leukemia
ADC Therapeutics S.A. 35
Not applicableActive Not RecruitingNCT02633111
What this trial is testing

DNA Sequencing-Based Monitoring of Minimal Residual Disease to Predict Clinical Relapse in Aggressive B-cell Non-Hodgkin Lymphomas

Who this might be right for
B-cell Non-Hodgkin LymphomaAggressive
Memorial Sloan Kettering Cancer Center 501
Not applicableNot Yet RecruitingNCT07286539
What this trial is testing

Precision Physical Exercise for Personalized Onco-Hematology.

Who this might be right for
Hematologic CancerColon CancerBreast Cancer+3 more
University of Salamanca 150
Testing effectiveness (Phase 2)Looking for participantsNCT05280275
What this trial is testing

Investigate the Safety and Clinical Activity of Belantamab Mafodotin in Combination With Daratumumab, Lenalidomide and Dexamethasone in Patients With Newly Diagnosed Multiple Myeloma Transplant Ineligible

Who this might be right for
Multiple MyelomaNeoplasmsNeoplasms, Plasma Cell+5 more
Hellenic Society of Hematology 36
Testing effectiveness (Phase 2)Study completedNCT00000838
What this trial is testing

Antiviral Activity of and Resistance to Lamivudine in Combination With Zidovudine, Stavudine, or Didanosine

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 256
Load More Results